Status | Study |
Completed |
Study Name: Evaluation of a New Ebola Vaccine Using a Short-interval Prime-boost Vaccination Condition: Ebola Virus Disease Date: 2015-06-25 Interventions: Biological: ChAd3-EBO Z This i |
Active, not recruiting |
Study Name: A Study to Assess Ebola Vaccines ChAd3-EBO-Z and Ad26.ZEBOV Condition: Ebola Virus Disease Date: 2015-06-18 Interventions: Biological: ChAd3-EBO-Z Biological: Ad26.Z |
Active, not recruiting |
Study Name: A Phase I Study to Assess Ebola Vaccines cAd3-EBO Z and MVA-EBO Z Condition: Ebola Virus Disease Date: 2015-05-07 Interventions: Biological: MVA-EBO Z Biological: ChAd3-EB |
Recruiting |
Study Name: Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up Condition: Ebola Virus Disease Date: 2015-04-30 |
Completed |
Study Name: A Phase I Trial to Evaluate Ad5-EBOV in Healthy Adult Africans in China. Condition: Ebola Virus Disease Date: 2015-03-24 Interventions: Biological: Ad5-EBOV intramuscular injection |
Recruiting |
Study Name: Multiple Treatments for Ebola Virus Disease (EVD) Condition: Ebola Virus Disease Date: 2015-03-01 Interventions: Drug: Azithromycin Adults (> |
Completed |
Study Name: Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Vaccine in Healthy Subjects Condition: Ebola Date: 2015-02-10 Interventions: Biological: Base Dose EBOV GP Vaccine Biol |
Active, not recruiting |
Study Name: Partnership for Research on Ebola Vaccines in Liberia (PREVAIL) Condition: Ebola Virus Date: 2015-01-22 Interventions: Biological: VSVG-ZEBOV The VSV |
Enrolling by invitation |
Study Name: Clinical Trial to Evaluate the Efficacy and Safety of Convalescent Plasma for Ebola Treatment Condition: Ebola Virus Disease Date: 2015-01-05 Interventions: Procedure: Convalescent Plasma Treatment This pilot trial will treat subjects in the ECP Group with ECP |
Completed |
Study Name: A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults. Condition: Ebola Virus Disease Date: 2014-12-22 Interventions: Biological: Low dose Ebola Zaire vaccine (Ad5-EBOV) |